Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Jun 1.

Published in final edited form as: Stroke. 2021 May 18;52(6):e263–e265. doi: 10.1161/STROKEAHA.121.034995

Table.

Ongoing trials comparing blood pressure management protocols after successful reperfusion with endovascular therapy

Name	Identifier^*	Location	SBP target (mmHg) by group		Primary outcomes	Estimated year of completion
Name	Identifier^*	Location	Experimental	Control	Primary outcomes	Estimated year of completion
Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2)	NCT04140110	China	<120 ^**	140–180	shift in mRS scores at 90 days	2023
Outcome in Patients Treated With Intraarterial Thrombectomy - optiMAL Blood Pressure Control (OPTIMAL-BP)	NCT04205305	South Korea	<140 ^**	<180	-mRS 0–2 at 90 days -symptomatic intracerebral hemorrhage -death at 90 days	2024
Blood Pressure After Endovascular Stroke Therapy-II (BEST-II)	NCT04116112	USA	−<160 ^ −<140 ^	<180	Final infarct volume Utility-weighted mRS at 90 days	2023

mRS denotes modified Rankin scale, SBP systolic blood pressure

^*

ClinicalTrials.gov

^**

To be achieved within 60 minutes of randomization